103
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Over-reaching beyond disease activity: the influence of anxiety and medical economic burden on health-related quality of life in patients with inflammatory bowel disease

, , , , , , , , & show all
Pages 23-31 | Published online: 22 Dec 2016

References

  • BassiADoddSWilliamsonPBodgerKCost of illness of inflammatory bowel disease in the UK: a single centre retrospective studyGut200453101471147815361497
  • CasellasFLópez-VivancosJCasadoAMalageladaJRFactors affecting health related quality of life of patients with inflammatory bowel diseaseQual Life Res200211877578112482161
  • BernklevTJahnsenJLygrenIHenriksenMVatnMMoumBHealth-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population normsInflamm Bowel Dis2005111090991816189421
  • LeongRWHuangTKoYProspective validation study of the international classification of functioning, disability and health score in Crohn’s disease and ulcerative colitisJ Crohns Colitis20148101237124524662396
  • IrvineEJQuality of life issues in patients with inflammatory bowel diseaseAm J Gastroenterol19979212 suppl18S24S9395348
  • LönnforsSVermeireSGrecoMHommesDBellCAvedanoLIBD and health-related quality of life – discovering the true impactJ Crohns Colitis20148101281128624662394
  • GraffLAWalkerJRBernsteinCNDepression and anxiety in inflammatory bowel disease: a review of comorbidity and managementInflamm Bowel Dis20091571105111819161177
  • SajadinejadMSAsgariKMolaviHKalantariMAdibiPPsychological issues in inflammatory bowel disease: an overviewGastroenterol Res Pract2012201210650222778720
  • PersoonsPVermeireSDemyttenaereKThe impact of major depressive disorder on the short- and long-term outcome of Crohn’s disease treatment with infliximabAliment Pharmacol Ther200522210111016011668
  • MittermaierCDejacoCWaldhoerTImpact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up studyPsychosom Med2004661798414747641
  • Blondel-KucharskiFChircopCMarquisPGroupe d’Etudes Thérapeutique des Affections Inflammatoires Digestives (GETAID)Health-related quality of life in Crohn’s disease: a prospective longitudinal study in 231 patientsAm J Gastroenterol200196102915292011693326
  • SimrénMAxelssonJGillbergRAbrahamssonHSvedlundJBjörnssonESQuality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factorsAm J Gastroenterol200297238939611866278
  • DunlopDDSongJLyonsJSManheimLMChangRWRacial/ethnic differences in rates of depression among preretirement adultsAm J Public Health200393111945195214600071
  • LeongRWLawranceICChingJYKnowledge, quality of life, and use of complementary and alternative medicine and therapies in inflammatory bowel disease: a comparison of Chinese and Caucasian patientsDig Dis Sci200449101672167615573925
  • GuyattGMitchellAIrvineEJA new measure of health status for clinical trials in inflammatory bowel diseaseGastroenterology19899638048102644154
  • RenWHLaiMChenYIrvineEJZhouYXValidation of the mainland Chinese version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for ulcerative colitis and Crohn’s diseaseInflamm Bowel Dis200713790391017309070
  • WareJJSherbourneCDThe MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selectionMed Care1992304734831593914
  • ZigmondASSnaithRPThe hospital anxiety and depression scaleActa Psychiatr Scand19836763613706880820
  • CohenSKamarckTMermelsteinRA global measure of perceived stressJ Health Soc Behav1983243853966668417
  • ZimetGDPowellSSFarleyGKWerkmanSBerkoffKAPsychometric characteristics of the multidimensional scale of perceived social supportJ Pers Assess1990553–46106172280326
  • HarveyRFBradshawJMA simple index of Crohn’s-disease activityLancet1980181675146102236
  • SchroederKWTremaineWJIlstrupDMCoated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized studyN Engl J Med198731726162516293317057
  • GibsonPRVaizeyCBlackCMRelationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: a cross-sectional, observational studyJ Crohns Colitis20148759860624345767
  • Van AsscheGDignassAPanesJThe second European evidence-based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosisJ Crohns Colitis2010472721122488
  • DignassAEliakimRMagroFSecond European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosisJ Crohns Colitis2012696599023040452
  • GuthrieEJacksonJShafferJThompsonDTomensonBCreedFPsychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn’s diseaseAm J Gastroenterol20029781994199912190166
  • VidalAGomez-GilESansMHealth-related quality of life in inflammatory bowel disease patients: the role of psychopathology and personalityInflamm Bowel Dis200814797798318275078
  • KimESChoKBParkKSDaegukyungbook Gastrointestinal Study Group (DGSG)Predictive factors of impaired quality of life in Korean patients with inactive inflammatory bowel disease: association with functional gastrointestinal disorders and mood disordersJ Clin Gastroenterol2013474e38e4423090047
  • NahonSLahmekPDuranceCRisk factors of anxiety and depression in inflammatory bowel diseaseInflamm Bowel Dis201218112086209122294486
  • HäuserWJankeKHKlumpBHinzAAnxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general populationInflamm Bowel Dis201117262163220848528
  • LoftusEJGuerinAYuAPIncreased risks of developing anxiety and depression in young patients with Crohn’s diseaseAm J Gastroenterol201110691670167721537359
  • WalkerJREdigerJPGraffLAThe Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disordersAm J Gastroenterol200810381989199718796096
  • ZhangCKHewettJHemmingJThe influence of depression on quality of life in patients with inflammatory bowel diseaseInflamm Bowel Dis20131981732173923669400
  • MawdsleyJERamptonDSPsychological stress in IBD: new insights into pathogenic and therapeutic implicationsGut200554101481149116162953
  • BoyeBLundinKEJantschekGINSPIRE study: does stress management improve the course of inflammatory bowel disease and disease-specific quality of life in distressed patients with ulcerative colitis or Crohn’s disease? A randomized controlled trialInflamm Bowel Dis20111791863187321287660
  • OliveiraSZaltmanCEliaCQuality-of-life measurement in patients with inflammatory bowel disease receiving social supportInflamm Bowel Dis200713447047417206693
  • LarssonKLööfLRönnblomANordinKQuality of life for patients with exacerbation in inflammatory bowel disease and how they cope with disease activityJ Psychosom Res200864213914818222127
  • GraffLAWalkerJRLixLThe relationship of inflammatory bowel disease type and activity to psychological functioning and quality of lifeClin Gastroenterol Hepatol20064121491150117162241
  • CasellasFArenasJIBaudetJSImpairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter studyInflamm Bowel Dis200511548849615867589
  • MoradkhaniABeckmanLJTabibianJHHealth-related quality of life in inflammatory bowel disease: psychosocial, clinical, socioeconomic, and demographic predictorsJ Crohns Colitis20137646747322884758
  • OdesSVardiHFrigerMClinical and economic outcomes in a population-based European cohort of 948 ulcerative colitis and Crohn’s disease patients by Markov analysisAliment Pharmacol Ther201031773574420047578
  • BurischJJessTMartinatoMLakatosPLECCO-EpiComThe burden of inflammatory bowel disease in EuropeJ Crohns Colitis20137432233723395397
  • KappelmanMDRifas-ShimanSLPorterCQDirect health care costs of Crohn’s disease and ulcerative colitis in US children and adultsGastroenterology200813561907191318854185